Cargando…

Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy

Cannabidiol is used in the care of treatment-resistant epilepsy. It has been associated with varying side effects, ranging from somnolence to diarrhea and weight loss. We present a patient on chronic cannabidiol therapy who had persistent diarrhea, abdominal pain, weight loss, and esophageal eosinop...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Maitri, Middleton, Jeremy P., Goodkin, Howard P., Barnes, Barrett, McGowan, Emily, Eid, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158314/
https://www.ncbi.nlm.nih.gov/pubmed/37168471
http://dx.doi.org/10.1097/PG9.0000000000000253
_version_ 1785036903387496448
author Patel, Maitri
Middleton, Jeremy P.
Goodkin, Howard P.
Barnes, Barrett
McGowan, Emily
Eid, Ryan
author_facet Patel, Maitri
Middleton, Jeremy P.
Goodkin, Howard P.
Barnes, Barrett
McGowan, Emily
Eid, Ryan
author_sort Patel, Maitri
collection PubMed
description Cannabidiol is used in the care of treatment-resistant epilepsy. It has been associated with varying side effects, ranging from somnolence to diarrhea and weight loss. We present a patient on chronic cannabidiol therapy who had persistent diarrhea, abdominal pain, weight loss, and esophageal eosinophilia that improved with cannabidiol dose adjustment.
format Online
Article
Text
id pubmed-10158314
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins, Inc.
record_format MEDLINE/PubMed
spelling pubmed-101583142023-05-09 Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy Patel, Maitri Middleton, Jeremy P. Goodkin, Howard P. Barnes, Barrett McGowan, Emily Eid, Ryan JPGN Rep Case Report Cannabidiol is used in the care of treatment-resistant epilepsy. It has been associated with varying side effects, ranging from somnolence to diarrhea and weight loss. We present a patient on chronic cannabidiol therapy who had persistent diarrhea, abdominal pain, weight loss, and esophageal eosinophilia that improved with cannabidiol dose adjustment. Lippincott Williams & Wilkins, Inc. 2022-09-30 /pmc/articles/PMC10158314/ /pubmed/37168471 http://dx.doi.org/10.1097/PG9.0000000000000253 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Patel, Maitri
Middleton, Jeremy P.
Goodkin, Howard P.
Barnes, Barrett
McGowan, Emily
Eid, Ryan
Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
title Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
title_full Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
title_fullStr Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
title_full_unstemmed Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
title_short Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
title_sort persistent diarrhea and eosinophilic esophagitis resulting from chronic cannabidiol usage for refractory epilepsy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158314/
https://www.ncbi.nlm.nih.gov/pubmed/37168471
http://dx.doi.org/10.1097/PG9.0000000000000253
work_keys_str_mv AT patelmaitri persistentdiarrheaandeosinophilicesophagitisresultingfromchroniccannabidiolusageforrefractoryepilepsy
AT middletonjeremyp persistentdiarrheaandeosinophilicesophagitisresultingfromchroniccannabidiolusageforrefractoryepilepsy
AT goodkinhowardp persistentdiarrheaandeosinophilicesophagitisresultingfromchroniccannabidiolusageforrefractoryepilepsy
AT barnesbarrett persistentdiarrheaandeosinophilicesophagitisresultingfromchroniccannabidiolusageforrefractoryepilepsy
AT mcgowanemily persistentdiarrheaandeosinophilicesophagitisresultingfromchroniccannabidiolusageforrefractoryepilepsy
AT eidryan persistentdiarrheaandeosinophilicesophagitisresultingfromchroniccannabidiolusageforrefractoryepilepsy